Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, March 24, 2016
[ Thu, Mar 24th 2016
] - WOPRAI
[ Thu, Mar 24th 2016
] - WOPRAI
[ Thu, Mar 24th 2016
] - WOPRAI
[ Thu, Mar 24th 2016
] - WOPRAI
[ Thu, Mar 24th 2016
] - WOPRAI
[ Thu, Mar 24th 2016
] - WOPRAI
[ Thu, Mar 24th 2016
] - WOPRAI
Wed, March 23, 2016
[ Wed, Mar 23rd 2016
] - WOPRAI
[ Wed, Mar 23rd 2016
] - WOPRAI
[ Wed, Mar 23rd 2016
] - WOPRAI
[ Wed, Mar 23rd 2016
] - WOPRAI
[ Wed, Mar 23rd 2016
] - WOPRAI
Tue, March 22, 2016
[ Tue, Mar 22nd 2016
] - WOPRAI
[ Tue, Mar 22nd 2016
] - WOPRAI
[ Tue, Mar 22nd 2016
] - WOPRAI
[ Tue, Mar 22nd 2016
] - WOPRAI
[ Tue, Mar 22nd 2016
] - WOPRAI
[ Tue, Mar 22nd 2016
] - WOPRAI
[ Tue, Mar 22nd 2016
] - WOPRAI
[ Tue, Mar 22nd 2016
] - WOPRAI
[ Tue, Mar 22nd 2016
] - WOPRAI
Kennen MacKay Maintained (BMRN) at Buy with Decreased Target to $109 on, Mar 22nd, 2016
Kennen MacKay of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $114 to $109 on, Mar 22nd, 2016.
Kennen has made no other calls on BMRN in the last 4 months.
There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Kennen's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kennen
- Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $105 on, Friday, February 26th, 2016
- Joseph Schwartz of "Leerink Swann" Maintained at Buy with Decreased Target to $120 on, Tuesday, February 23rd, 2016
Similar Stocks and Investing Articles
[ Fri, Mar 11th 2016
] - WOPRAI
[ Fri, Mar 11th 2016
] - WOPRAI
[ Tue, Mar 08th 2016
] - WOPRAI
[ Thu, Mar 03rd 2016
] - WOPRAI
[ Fri, Feb 26th 2016
] - WOPRAI
[ Fri, Feb 26th 2016
] - WOPRAI
[ Wed, Mar 20th 2013
] - WOPRAI
[ Wed, Mar 20th 2013
] - WOPRAI
[ Tue, Feb 19th 2013
] - WOPRAI
[ Tue, Feb 12th 2013
] - WOPRAI